Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis in rats by fenbendazole - A CYP1A2 inducer

Cancer Letters

Volumn 185, Issue 1, 2002, Pages 39-45

  Suzuki, Shugo ^a   Takahashi, Satoru ^a   Asamoto, Makoto ^a   Inaguma, Shingo ^a   Ogiso, Tadashi ^a   Hirose, Masao ^b   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

2 Amino 3,8 dimethylimidazo 4,5 f quinoxaline; CYP1A2; Fenbendazole; Hepatocarcinogenesis; Rat

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; CYTOCHROME P450 1A2; FENBENDAZOLE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; 2 AMINO 3,8 DIMETHYLIMIDAZO(4,5 F)QUINOXALINE; 2-AMINO-3,8-DIMETHYLIMIDAZO(4,5-F)QUINOXALINE; ANTINEMATODAL AGENT; ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; PRIMER DNA; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION; LIVER CARCINOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME IMMUNOASSAY; ENZYMOLOGY; FISCHER 344 RAT; GENETICS; LIVER; LIVER CELL CARCINOMA; LIVER MICROSOME; LIVER TUMOR; METABOLISM; WESTERN BLOTTING;

ANIMAL; ANTINEMATODAL AGENTS; ARYLAMINE N-ACETYLTRANSFERASE; BLOTTING, WESTERN; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CYTOCHROME P-450 CYP1A2; DNA PRIMERS; DRUG COMBINATIONS; DRUG SYNERGISM; ENZYME INDUCTION; FENBENDAZOLE; GLUTATHIONE TRANSFERASE; IMMUNOENZYME TECHNIQUES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICROSOMES, LIVER; QUINOXALINES; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0037044564     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00243-4     Document Type: Article

References (25)

1. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today
2. Meat, cooking methods and colorectal cancer: A case-referent study in Stockholm
3. Intake of fried meat and risk of cancer: A follow-up study in Finland
4. Nutrition and dietary carcinogens
5. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat
6. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods
7. Exposure to heterocyclic amines
8. Heterocyclic aromatic amines in human urine following a fried meat meal
9. Presence of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5- f]quinoxaline (dG-C8-MeIQx) in human tissues
10. Metabolic activation and covalent and binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates
11. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
12. Chemotherapy of parasitic diseases and anticestodal drugs
13. Liver tumor promoting effects of fenbendazole in rats
14. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals
15. A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential: A historical review of model development and summary of results from 291 tests
16. Medium-term bioassays for carcinogens
17. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses
18. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses
19. Lack of carcinogenicity of pesticide mixtures administered in the diet at acceptable daily intake (ADI) dose levels in rats
20. Control of the mutagenicity of aromatic amines by protein kinases and phosphatases
21. Control of the mutagenicity of arylamines by protein kinases and phosphatases
22. Regioselective differences in C(8)- and N-oxidation of -amino-3,8- dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2
23. Recombinant human P450 forms 1A1, 1A2 and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains
24. Evaluation of certain veterinary drug residues in food
25. Dietary intake estimates as a means to the harmonization of maximum residue levels for veterinary drugs